Cannabis Sativa Past Earnings Performance
Past criteria checks 0/6
Cannabis Sativa has been growing earnings at an average annual rate of 23.5%, while the Healthcare industry saw earnings growing at 5.3% annually. Revenues have been declining at an average rate of 1.6% per year.
Key information
23.5%
Earnings growth rate
41.1%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | -1.6% |
| Return on equity | -377.7% |
| Net Margin | -115.4% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Cannabis Sativa makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 1 | -1 | 1 | 0 |
| 31 Mar 24 | 1 | -1 | 1 | 0 |
| 31 Dec 23 | 1 | -1 | 1 | 0 |
| 30 Sep 23 | 1 | -2 | 2 | 0 |
| 30 Jun 23 | 1 | -2 | 2 | 0 |
| 31 Mar 23 | 1 | -2 | 2 | 0 |
| 31 Dec 22 | 2 | -1 | 2 | 0 |
| 30 Sep 22 | 2 | -1 | 2 | 0 |
| 30 Jun 22 | 2 | -2 | 2 | 0 |
| 31 Mar 22 | 2 | -2 | 3 | 0 |
| 31 Dec 21 | 2 | -2 | 3 | 0 |
| 30 Sep 21 | 2 | -2 | 3 | 0 |
| 30 Jun 21 | 2 | -1 | 3 | 0 |
| 31 Mar 21 | 2 | -1 | 3 | 0 |
| 31 Dec 20 | 2 | -1 | 3 | 0 |
| 30 Sep 20 | 2 | -3 | 3 | 0 |
| 30 Jun 20 | 2 | -4 | 3 | 0 |
| 31 Mar 20 | 2 | -4 | 3 | 0 |
| 31 Dec 19 | 1 | -4 | 3 | 0 |
| 30 Sep 19 | 1 | -3 | 2 | 0 |
| 30 Jun 19 | 0 | -3 | 2 | 0 |
| 31 Mar 19 | 1 | -4 | 3 | 0 |
| 31 Dec 18 | 1 | -4 | 4 | 0 |
| 30 Sep 18 | 1 | -5 | 5 | 0 |
| 30 Jun 18 | 1 | -6 | 6 | 0 |
| 31 Mar 18 | 0 | -7 | 6 | 0 |
| 31 Dec 17 | 0 | -8 | 7 | 0 |
| 30 Sep 17 | 0 | -7 | 7 | 0 |
| 30 Jun 17 | 0 | -7 | 6 | 0 |
| 31 Mar 17 | 0 | -5 | 4 | 0 |
| 31 Dec 16 | 0 | -3 | 3 | 0 |
| 30 Sep 16 | 0 | -5 | 4 | 0 |
| 30 Jun 16 | 0 | -6 | 6 | 0 |
| 31 Mar 16 | 0 | -8 | 8 | 0 |
| 31 Dec 15 | 0 | -9 | 9 | 0 |
| 30 Sep 15 | 0 | -19 | 6 | 0 |
| 30 Jun 15 | 0 | -18 | 5 | 0 |
| 31 Mar 15 | 0 | -16 | 3 | 0 |
| 31 Dec 14 | 0 | -14 | 1 | 0 |
| 30 Sep 14 | 0 | -44 | 0 | 0 |
| 31 Dec 13 | 0 | -43 | 0 | 0 |
Quality Earnings: CBDS is currently unprofitable.
Growing Profit Margin: CBDS is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CBDS is unprofitable, but has reduced losses over the past 5 years at a rate of 23.5% per year.
Accelerating Growth: Unable to compare CBDS's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CBDS is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (10.3%).
Return on Equity
High ROE: CBDS has a negative Return on Equity (-377.71%), as it is currently unprofitable.